Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer
Public ClinicalTrials.gov record NCT01956812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An International, Multi-Center, Double-Blind, Randomized, Phase III Trial of 90Y-Clivatuzumab Tetraxetan Plus Low-Dose Gemcitabine Versus Placebo Plus Low-Dose Gemcitabine in Patients With Metastatic (Stage IV) Pancreatic Adenocarcinoma Who Received at Least Two Prior Treatments (PANCRIT-1)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The is a double-blind, randomized phase 3 study of 90Y-clivatuzumab tetraxetan with low-dose gemcitabine, versus placebo and low-dose gemcitabine in metastatic pancreatic cancer patients who have progressed on at least 2 prior therapies for metastatic cancer (1 of which was a gemcitabine-containing regimen).
Study identification
- NCT ID
- NCT01956812
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 334 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2013 (Actual)
- Primary completion
- Nov 2016 (Actual)
- Completion
- Nov 2016 (Actual)
- Last update posted
- Aug 16, 2021
2013 – 2016
United States locations
- U.S. sites
- 42
- U.S. states
- 24
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner MD Anderson | Gilbert | Arizona | 85234 | — |
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| Pacific Shores Medical Group | Long Beach | California | 90813 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Whittingham Cancer Center | Norwalk | Connecticut | 06856 | — |
| Michael and Dianne Bienes Comprehensive Cancer Center - Holy Cross Hospital | Fort Lauderdale | Florida | 33308 | — |
| Baptist Cancer Institute | Jacksonville | Florida | 32207 | — |
| Cancer Specialists of North Florida | Jacksonville | Florida | 32256 | — |
| Mountain States Tumor Institute at St. Luke's Regional Medical Center | Boise | Idaho | 83712 | — |
| Illinois Cancer Specialists | Arlington Heights | Illinois | 60005 | — |
| Indiana University Health Goshen Center for Cancer Care | Goshen | Indiana | 46526 | — |
| Indiana University Melvin and Bren Simon Cancer Center | Indianapolis | Indiana | 46202 | — |
| Ashland-Bellefonte Cancer Center | Ashland | Kentucky | 41101 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Masonic Cancer Center, University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39213 | — |
| Oncology Hematology West P.C. dba Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| New York Presbyterian Hospital/Weill Cornell Medical Center | New York | New York | 10021 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Stony Brook University Medical Center | Stony Brook | New York | 11794-7007 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13210 | — |
| University of North Carolina Hospitals, Lineberger Comprehensive Cancer Center | Chapel Hill | North Carolina | 27599-7510 | — |
| The Ohio State University - Comprehensive Cancer Center | Columbus | Ohio | 43210 | — |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | — |
| The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033-0850 | — |
| University of Pennsylvania Abramson Cancer Center | Philadelphia | Pennsylvania | 19104 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| University of Pittsburgh Medical Center/Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| Center for Biomedical Research | Knoxville | Tennessee | 37909 | — |
| University of Tennessee Medical Center, Cancer Institute | Knoxville | Tennessee | 37920 | — |
| Mary Crowley Medical Research Center | Dallas | Texas | 75251 | — |
| Oncology Consultants | Houston | Texas | 77030 | — |
| Texas Oncology - McAllen | McAllen | Texas | 78503 | — |
| Texas Oncology - Tyler | Tyler | Texas | 75702 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| University of Washington | Seattle | Washington | 98109 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98111 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01956812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 16, 2021 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01956812 live on ClinicalTrials.gov.